grant

Assessing efficacy of polyfunctional nanoparticles engineered for the delivery of multiple therapeutics in reduction of cardiac ischemia reperfusion injury [ 2014 - 2020 ]

Also known as: Nanoparticles for the delivery of therapeutics to alleviate cardiac ischemia reperfusion injury

Funded by National Health and Medical Research Council
Managed by The University of Western Australia
Managed by University of Western Australia
Provided by   National Health and Medical Research Council

Research Grant

[Cite as http://purl.org/au-research/grants/nhmrc/1073180]

Brief description A reduction in heart muscle damage after a heart attack is associated with a reduction in heart failure and an increase in life expectancy. However to date many therapeutic agents are not successful at reducing muscle damage because of difficulty in delivering the drugs to the target site. This project will address these delivery issues by making use of multifunctional nanoparticles which will allow for targeted delivery and release of therapeutics directly to damaged tissue following injury.

Funding Amount $AUD 317,678.18

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF

Click to explore relationships graph
Help

Related Organisations

Subjects
Cardiorespiratory Medicine and Haematology | Cardiology (Incl. Cardiovascular Diseases) | Medical and Health Sciences | cardiac hypertrophy | cardiac ischaemia | cardiovascular disease | infarction | ischaemia/reperfusion |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA